A Community Health Education Intervention for Increasing Community-driven Actions to Reduce the Cancer Burden in Western New York

ConditionHealthy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRoswell Park Cancer Institute

About this trial

This clinical trial evaluates a community health education intervention (I CAN) for increasing community-driven actions to reduce the cancer burden in Western New York. Engaging community members is a critical component of designing impactful programs to reduce the cancer burden. Leaders at the national, state, and local levels have all called for more community partnerships and engagement in design of health intervention and policies. The I CAN intervention is a workshop that includes a presentation outlining key concepts related to social network processes and the cancer burden in Western New York, a structured skill-building activity, and then empowering and motivating activities meant to cultivate momentum and excitement for action. This community health education intervention may be able to provide a formalized process for empowering and facilitating community members to take steps to reduce the community cancer burden.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Being over 18 years old

Able to participate in English

Disqualifiers

Unwilling or unable to follow protocol requirements

Trial design

Design model

Single group

Treatments tested in this trial

  • Community Health Education

    Procedure/Surgery

    Receive I CAN intervention

  • Telephone Based Intervention

    Behavioral

    Receive coaching call

Treatment groups

500 Participants
are divided into 2 treatment groups
Group A: Prevention (I CAN intervention) - Phase 1Experimental treatment 1 intervention
Group B: I CAN Intervention - Phase 2Experimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Demand - Phase 1

Feasibility will be assessed through demand, which will be evaluated as the number of people enrolled and the demographics of participants. Descriptive analyses will be used.

Time frame
Up to 2 years
2

Practicality - Phase 1

Practicality will be assessed through the percentage of participants who complete different aspects of the intervention. Descriptive analyses will be used.

Time frame
Up to 2 years
3

Acceptability- Phase 1

Acceptability will be examined through post-intervention measures, including the Acceptability of Intervention Measure, Intervention Appropriateness Measure, and Feasibility of Intervention Measure. Descriptive analyses will be used.

Time frame
Up to 2 years
4

Lung Cancer Screening Uptake

Will be assessed by determining if I CAN intervention results in higher number of individuals who complete lung cancer screening

Time frame
Up to 2 years

Secondary outcomes

1

Rate of follow up for Lung cancer screening

Time frame
6 months post screening (estimated to be 2 years)

Other outcomes

1

Lung Cancer Screening knowledge - Phase 2

Will be compared between arms using an 8 item survey of True/False questions

Time frame
initial assessment and 6 months post screening (estimated to be up to 2 years)

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Roswell Park Cancer Institute

Lead sponsor

Merck Sharp & Dohme LLC

Collaborator

National Comprehensive Cancer Network

Collaborator